ClinicalTrials.Veeva

Menu

Pilot Study of Measurement Agreement Between Morphological and Diffusion Tensor Imaging MRI for Pelvic Nerve Cartography (NERVWATCH)

C

Centre Hospitalier Universitaire de Nīmes

Status

Enrolling

Conditions

Pelvic MRI

Treatments

Other: MRI

Study type

Observational

Funder types

Other

Identifiers

NCT03320343
NIMAO/2017-01/MB-01

Details and patient eligibility

About

The investigators hypothesize that diffusion tensor imaging (DTI) will produce a similar map of autonomic pelvic innervation to that obtained using 3D morphological MRI sequences

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient it at least 18 years old
  • The patient has been admitted for an MRI examination of the pelvic region, for any reason

Exclusion criteria

  • The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The patient is pregnant or breast feeding
  • There is a contra-indication for MRI (pacemaker, claustrophobic patient)
  • The patient has had previous pelvic surgery

Trial design

20 participants in 1 patient group

Patients recruited for pelvic imaging examination
Treatment:
Other: MRI

Trial contacts and locations

1

Loading...

Central trial contact

Martin Bertrand, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems